Fig. 3
From: The role of 18F-FDG PET/CT in distinguishing benign from malignant portal vein thrombosis
A 67-year-old male patient with liver cirrhosis and right hepatic lobe HCC lesion associated with right portal vein malignant thrombosis. a–c Axial contrast-enhanced MSCT, axial fused PET/CT, and axial PET images. d–f Coronal contrast-enhanced MSCT, coronal fused PET/CT, and coronal PET images revealed linear increased FDG uptake (SUVmax 4) corresponding to right portal vein malignant thrombosis (orange arrows) and increased FDG uptake corresponding to right hepatic lobe HCC lesion (white arrows) and porta hepatis metastatic lymph nodes (blue arrows). Also note increased FDG uptake in the regional spine corresponding to metastatic spinal deposits